Can-Fite BioPharma Ltd. (CANF) Operating cash flow 2017–2025
Can-Fite BioPharma Ltd. (CANF) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$8.9MFY2025 · since FY2017: -$9.0M → -$8.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.9M | -17.2% |
| FY2024 | -$7.6M | +9.5% |
| FY2023 | -$8.4M | +21.9% |
| FY2022 | -$10.8M | -9.6% |
| FY2021 | -$9.9M | +18.3% |
| FY2020 | -$12.1M | -8.8% |
| FY2019 | -$11.1M | -166.8% |
| FY2018 | -$4.2M | +53.7% |
| FY2017 | -$9.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice